Schroder Investment Management Group Adaptive Biotechnologies Corp Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$3.46 - $5.33 $208,776 - $321,612
-60,340 Reduced 14.16%
365,656 $1.79 Million
Q3 2023

Nov 14, 2023
SELL
$5.07 - $8.44 $242,290 - $403,339
-47,789 Reduced 10.09%
425,996 $2.32 Million
Q4 2022

Feb 10, 2023
BUY
$6.26 - $9.34 $2.97 Million - $4.43 Million
473,785 New
473,785 $3.62 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email